| Raghavendra R Allareddy, | |
|
9500 Euclid Ave, Cleveland, OH 44195-0001 | |
| (800) 223-2273 | |
| Not Available |
| Full Name | Raghavendra R Allareddy |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 39 Years |
| Location | 9500 Euclid Ave, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124131214 | NPI | - | NPPES |
| 2590763 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 35086559 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
LUMEDX Corporation, a leading provider of fully integrated, vendor-neutral cardiovascular imaging and information systems, announced today that it has begun implementing the HealthView Chest Pain Management solution at five Methodist Healthcare facilities in San Antonio, Texas.
A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston. The drug reduced disease activity as indicated by MRI scans.
A group of prevention-focused healthcare organizations has expressed deep concern over recently-proposed restrictions to OHIP coverage of Vitamin D testing in the province. The proposed new legislation will delist OHIP insured Vitamin D testing for most Ontarians. Exceptions will be made for those with osteoporosis, malabsorption syndromes, and individuals taking medications that interfere with vitamin D absorption or metabolism.
Several scientific papers with results from one of Europe's largest health surveys of young children with focus on overweight and obesity, the IDEFICS study, have been published the last years. Research at the Nordic School of Public Health NHV reveals that some types of families seem to be underrepresented in the health survey. This knowledge can prove to be valuable when the data is interpreted and can contribute to efficient actions for improved child health.
In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die.
› Verified 6 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
LUMEDX Corporation, a leading provider of fully integrated, vendor-neutral cardiovascular imaging and information systems, announced today that it has begun implementing the HealthView Chest Pain Management solution at five Methodist Healthcare facilities in San Antonio, Texas.
A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston. The drug reduced disease activity as indicated by MRI scans.
A group of prevention-focused healthcare organizations has expressed deep concern over recently-proposed restrictions to OHIP coverage of Vitamin D testing in the province. The proposed new legislation will delist OHIP insured Vitamin D testing for most Ontarians. Exceptions will be made for those with osteoporosis, malabsorption syndromes, and individuals taking medications that interfere with vitamin D absorption or metabolism.
Several scientific papers with results from one of Europe's largest health surveys of young children with focus on overweight and obesity, the IDEFICS study, have been published the last years. Research at the Nordic School of Public Health NHV reveals that some types of families seem to be underrepresented in the health survey. This knowledge can prove to be valuable when the data is interpreted and can contribute to efficient actions for improved child health.
In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die.
› Verified 6 days ago
| Entity Name | Mid-state Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598029498 PECOS PAC ID: 9032375878 Enrollment ID: O20120724000439 |
News Archive
LUMEDX Corporation, a leading provider of fully integrated, vendor-neutral cardiovascular imaging and information systems, announced today that it has begun implementing the HealthView Chest Pain Management solution at five Methodist Healthcare facilities in San Antonio, Texas.
A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston. The drug reduced disease activity as indicated by MRI scans.
A group of prevention-focused healthcare organizations has expressed deep concern over recently-proposed restrictions to OHIP coverage of Vitamin D testing in the province. The proposed new legislation will delist OHIP insured Vitamin D testing for most Ontarians. Exceptions will be made for those with osteoporosis, malabsorption syndromes, and individuals taking medications that interfere with vitamin D absorption or metabolism.
Several scientific papers with results from one of Europe's largest health surveys of young children with focus on overweight and obesity, the IDEFICS study, have been published the last years. Research at the Nordic School of Public Health NHV reveals that some types of families seem to be underrepresented in the health survey. This knowledge can prove to be valuable when the data is interpreted and can contribute to efficient actions for improved child health.
In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raghavendra R Allareddy, 6000 W Creek Rd, Suite 10, Independence, OH 44131-2139 Ph: (800) 223-2273 | Raghavendra R Allareddy, 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (800) 223-2273 |
News Archive
LUMEDX Corporation, a leading provider of fully integrated, vendor-neutral cardiovascular imaging and information systems, announced today that it has begun implementing the HealthView Chest Pain Management solution at five Methodist Healthcare facilities in San Antonio, Texas.
A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston. The drug reduced disease activity as indicated by MRI scans.
A group of prevention-focused healthcare organizations has expressed deep concern over recently-proposed restrictions to OHIP coverage of Vitamin D testing in the province. The proposed new legislation will delist OHIP insured Vitamin D testing for most Ontarians. Exceptions will be made for those with osteoporosis, malabsorption syndromes, and individuals taking medications that interfere with vitamin D absorption or metabolism.
Several scientific papers with results from one of Europe's largest health surveys of young children with focus on overweight and obesity, the IDEFICS study, have been published the last years. Research at the Nordic School of Public Health NHV reveals that some types of families seem to be underrepresented in the health survey. This knowledge can prove to be valuable when the data is interpreted and can contribute to efficient actions for improved child health.
In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die.
› Verified 6 days ago
Amir Razavi, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Dr. Francois Fadell, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18200 Lorain Ave, Moll Cancer Center At Fairview- Respiratory Institute, Cleveland, OH 44111 Phone: 216-444-6503 | |
Sana Hasan, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 Phone: 330-721-5700 | |
Catherine Frakes Vozzo, DO Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-4444 Fax: 216-445-6290 | |
Tarek Ashour, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # Q7, Cleveland, OH 44195 Phone: 216-444-5040 | |
Mrs. Efewongbe Benedicta Oleghe, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2351 E 22nd Street, St Vincent's Charity Medical Center, Cleveland, OH 44115 Phone: 216-363-2725 | |
Dr. Toufik Z. Madhun, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave Dept Of, Cleveland, OH 44106 Phone: 216-844-1000 |